FORWARD FEATURES CALENDAR

Find us on

Latest News

Private equity firms RedBird Capital Partners and Weatherford Capital have jointly launched Collegiate Athletic Solutions, a platform aiming to provide capital and advice to public and private university athletic departments in the US. 
Private equity’s challenges in returning capital to clients are increasingly affecting hedge funds, which depend on the same pool of institutional investors including pension plans, foundations, and endowments, for their fundraising efforts, according to a report by the Financial Times. 
The Institutional Investors Group on Climate Change has introduced guidance aimed at helping the private debt industry set and achieve net zero commitments. 
Abu Dhabi-based alternative investment manager Shorooq Partners has made the first close of its second $100m private credit fund, though the exact amount raised in this initial closing was not disclosed. 
Australian alternative asset manager HMC Capital has entered the private credit sector with an AUD127.5m acquisition of Melbourne-based real estate fund manager Payton Capital, according to a report by the Australian Financial Review. 
Debt advisory firm Cadence Advisory has appointed Joe Wood as a partner to “support organic growth and enhance sponsor-backed transactions”. 
Institutional investors in the US are increasingly turning to multi-asset credit strategies to capture alpha amid rising market volatility, according to a report by Pensions & Investments. 
London-based private equity giant Hg has agreed to acquire AuditBoard, a cloud-based platform for audit, risk, compliance and ESG management, in a transaction valued at over $3bn including debt. 
New York-based banking giant JPMorgan Chase & Co is actively seeking to acquire a private credit firm to strengthen its private capital operations within its $3.6tn asset management division, according to a report by Bloomberg. 
Paris-based private equity firm Jeito Capital will sell its portfolio company HI-Bio, a clinical-stage biotech company focused on immune-mediated diseases, to Biogen for $1.15bn. 

Special Reports

Featured

Events

12 November, 2026 – 8:00 am

Directory Listings